1
|
García-Agua Soler N, Gómez-Bermúdez E, Baixauli-Fernández VJ, Bellver-Beltrán S, Velasco-Martínez J, García Ruiz AJ, Jódar-Sánchez F. Medicines use review service in community pharmacies in Spain: REVISA project. Int J Clin Pharm 2020; 43:524-531. [PMID: 32996076 PMCID: PMC8214585 DOI: 10.1007/s11096-020-01158-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2020] [Accepted: 09/17/2020] [Indexed: 11/26/2022]
Abstract
Background Community pharmacy services play an important role in controlling some factors related to medicine use and patients can benefit from these services to improve the adherence and knowledge of their medications, besides to reduce medicine-related problems. Objective The aim of the REVISA project is to carry out a study on preliminary implementation of the medicines use review service in Spanish community pharmacies. Setting Sixty-four community pharmacies from all regions of Spain. Method A preliminary implementation, cross-sectional multicentre study was conducted using a convenience sample of voluntary community pharmacies. A structured interview enabled to pharmacists to obtain a better understanding of patient's medicines use. Main outcome measure Medicines use review-related time and cost, satisfaction and willingness to pay. Results A total of 495 patients were enrolled. The mean age of the patients was 66.1 years, with the majority females (56.4%) and a mean consumption of 5.7 medicines. A total of 2811 medicines were evaluated and 550 referral recommendations were made (29.8% to Primary Care). The mean time employed by the pharmacists in the medicines use review service was 52.8 min (medicines use review-related cost of €17.27). Most patients expressed a high level of satisfaction with this service (98.5%) and a willingness to pay for it (84%). Conclusion Medicines use review service in community pharmacies in Spain can be delivered, that it appears to be acceptable to patients and that most patients said they would be willing to pay for it. This service may offer an opportunity to promote inter-professional collaboration between pharmacists and general practitioners.
Collapse
Affiliation(s)
- Nuria García-Agua Soler
- Chair of Health Economics and Rational Use of Drugs, Department of Pharmacology. University of Málaga, Boulevard Louis Pasteur, 32, 29071, Málaga, Spain.
- Pharmacoeconomics: Clinical and Economic Evaluation of Pharmaceutical Drugs and Palliative Care, Institute of Biomedical Research in Malaga (IBIMA), Málaga, Spain.
- Illustrious in the Official College of Pharmacists of Málaga, Málaga, Spain.
- Subcommittee Medicines Use Review, Spanish Society of Family and Community Pharmacy (SEFAC-Sociedad Española de Farmacia Familiar y Comunitaria), Madrid, Spain.
| | - Eugenia Gómez-Bermúdez
- Subcommittee Medicines Use Review, Spanish Society of Family and Community Pharmacy (SEFAC-Sociedad Española de Farmacia Familiar y Comunitaria), Madrid, Spain
| | - Vicente J Baixauli-Fernández
- Subcommittee Medicines Use Review, Spanish Society of Family and Community Pharmacy (SEFAC-Sociedad Española de Farmacia Familiar y Comunitaria), Madrid, Spain
| | - Sara Bellver-Beltrán
- Subcommittee Medicines Use Review, Spanish Society of Family and Community Pharmacy (SEFAC-Sociedad Española de Farmacia Familiar y Comunitaria), Madrid, Spain
| | - Javier Velasco-Martínez
- Subcommittee Medicines Use Review, Spanish Society of Family and Community Pharmacy (SEFAC-Sociedad Española de Farmacia Familiar y Comunitaria), Madrid, Spain
| | - Antonio J García Ruiz
- Chair of Health Economics and Rational Use of Drugs, Department of Pharmacology. University of Málaga, Boulevard Louis Pasteur, 32, 29071, Málaga, Spain
- Pharmacoeconomics: Clinical and Economic Evaluation of Pharmaceutical Drugs and Palliative Care, Institute of Biomedical Research in Malaga (IBIMA), Málaga, Spain
| | - Francisco Jódar-Sánchez
- Group in Biomedical Informatics, Biomedical Engineering and Health Economy, Institute of Biomedicine of Seville, IBiS/Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain
| |
Collapse
|